SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-08-047873
Filing Date
2008-07-28
Accepted
2008-07-28 08:32:32
Documents
3
Period of Report
2008-07-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a08-20045_48k.htm 8-K 37846
2 EX-3.1 a08-20045_4ex3d1.htm EX-3.1 72279
3 EX-99.1 a08-20045_4ex99d1.htm EX-99.1 14132
  Complete submission text file 0001104659-08-047873.txt   126070
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Filer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32715 | Film No.: 08971989
SIC: 2835 In Vitro & In Vivo Diagnostic Substances